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Purpose: To explore the effects of three doses of caffeine on muscle strength and muscle 
endurance. 
Methods: Twenty-eight resistance-trained men completed the testing sessions under five 
conditions: no-placebo control, placebo-control, and with caffeine doses of 2, 4, and 6 
mg.kg−1. Muscle strength was assessed using the one-repetition maximum (1RM) test; muscle 
endurance was assessed by having the participants perform a maximal number of repetitions 
with 60% 1RM. 
Results: In comparisons with both control conditions, only a caffeine dose of 2 mg.kg−1 
enhanced lower-body strength (d=0.13–0.15). In comparisons with the no-placebo control 
condition, caffeine doses of 4 mg.kg−1 and 6 mg.kg−1 enhanced upper-body strength (d=0.07–
0.09) with a significant linear trend for the effectiveness of different doses of caffeine 
(p=0.020). Compared to both control conditions, all three caffeine doses enhanced lower-body 
muscle endurance (d=0.46–0.68). For upper-body muscle endurance, we did not find 
significant effects of caffeine. 
Conclusions: We found a linear trend between the dose of caffeine and its effects on upper-
body strength. This study found no clear association between the dose of caffeine and the 
magnitude of its ergogenic effects on lower-body strength and muscle endurance. From a 
practical standpoint, the magnitude of caffeine’s effects on strength is of questionable 
relevance. A low dose of caffeine (2 mg.kg−1)—for an 80kg individual, this dose of caffeine 
contained in one to two cups of coffee—may produce substantial improvements in lower-
body muscle endurance with the magnitude of the effect being similar to that attained using 





The use of caffeine is highly prevalent among both the general population and athletes.1,2 The 
International Olympic Committee has also identified caffeine as having strong scientific 
support for its ergogenic effects on exercise performance.3 There is good evidence that 
caffeine ingestion can acutely enhance aerobic and muscle endurance, muscle strength, 
power, jumping height, and exercise speed.4,5  
 
In research studies, caffeine is often administered in moderate to high doses (3 to 6 mg.kg−1), 
with 6 mg.kg−1 being the most common.4 There is, however, emerging interest in exploring 
the effects of lower doses of caffeine (≤3 mg.kg−1) on exercise performance as such doses 
generally provide an ergogenic benefit with minimal side-effects.6 While lower doses are 
ergogenic for exercise performance, there is a lack of studies exploring whether they provide 
similar performance-enhancing effects as more conventionally recommended intakes (i.e., 3 
to 6 mg.kg−1). Additionally, the evidence for the ergogenic effects of low doses of caffeine is 
largely based on studies using tests of aerobic endurance.6 There is a paucity of studies 
exploring the effects of such doses of caffeine on high-intensity, short-duration exercise 
performance (such as resistance exercise).6  
 
Caffeine ingestion has been demonstrated to be ergogenic for muscle strength and muscle 
endurance.7 One meta-analysis8 reported a significant effect of caffeine ingestion on one-
repetition maximum (1RM) strength. Of the ten studies included in that meta-analysis, nine 
used a single dose of caffeine (most commonly 6 mg.kg−1). One study used two different 
doses of caffeine (2 mg.kg−1 versus 5 mg.kg−1); however, their results were inconclusive given 




pooled the evidence for the effects of caffeine ingestion on muscle endurance.10 As with 
strength, the authors observed an ergogenic effect of caffeine. Of the sixteen studies that met 
the inclusion criteria for that review, all of them used a single caffeine dose (relative doses of 
≥4 mg.kg−1). Therefore, minimal effective doses of caffeine for muscle strength and 
endurance remain unclear due to the lack of studies using multiple doses of caffeine.  
 
To glean new insights into this topic, in the present study we aimed to explore the acute 
effects of three doses of caffeine (2, 4, and 6 mg.kg−1) on muscle strength and muscle 
endurance in resistance-trained men. We hypothesized that all doses of caffeine would 




To be included in the present study, participants had to satisfy the following criteria: (a) be 
apparently healthy men, aged between 18 and 45 years; (b) be resistance-trained, defined as 
having a minimum of one year of resistance training experience with a minimum weekly 
training frequency of two times per week (on most weeks); and (c) have the ability to perform 
the bench press and back squat exercises with a load corresponding to at least 100% of their 
body mass. Based on a power analysis using the G*Power software (Germany, Düsseldorf, 
version 3), with an effect size f of 0.10 for lower-body muscle endurance, alpha error of 0.05, 
statistical power of 80%, and r of 0.90,11 the minimum required sample size for this study was 
estimated to be 26 participants. To factor in possible dropouts, we initially recruited a sample 
of 32 men. During the study, four participants dropped out due to personal reasons. A sample 




mass: 89±11 kg), completed the trials. Habitual caffeine intake was assessed via a validated 
food frequency questionnaire (FFQ).12 A qualified nutritionist estimated the daily caffeine 
intake based on the responses to the FFQ. The mean ± standard deviation habitual caffeine 
intake of the whole sample was 112±165 mg.day−1. Ethical approval was requested and 
granted from the Committee for Scientific Research and Ethics of the Faculty of Kinesiology 
at the University of Zagreb, where the study was conducted. All participants were informed 
about the study requirements, benefits, and risks and provided their written informed consent 
before the involvement in the study. 
 
Experimental design 
Following the familiarization session, the participants were randomly assigned to five 
experimental conditions in a counterbalanced fashion. The conditions were: no-placebo 
control condition, placebo-control condition, and three caffeine conditions with caffeine doses 
of 2, 4, and 6 mg.kg−1. The placebo and caffeine powders were weighted using a high 
precision electronic digital scale and were administered in capsules of identical appearance to 
maintain a double-blind design. The testing sessions consisted of upper- and lower-body 
muscle strength and muscle endurance tests (Figure 1).   
 
To ensure that the exercise performance was not affected by circadian variation, all testing 
sessions were conducted at the same time of the day for each participant (23 participants were 
tested in the evening hours and five were tested in the morning hours). The participants came 
to each session after a three-hour fasting period. Testing was then carried out sixty minutes 
after supplement ingestion. Sessions were separated by no less than five and no more than 




training routines. The participants were instructed not to perform any vigorous exercise, to 
maintain their usual hydration, dietary habits, and sleep patterns in the 24 hours prior to each 
session. Also, the participants were requested to refrain from any caffeine ingestion 12 hours 
before the five sessions. Caffeine has a half-life of four to six hours; therefore, stopping its 
ingestion around 12 hours before the testing session is deemed sufficient to avoid potential 
confounding by prior caffeine ingestion.1 To facilitate this process, the participants were 
provided with a comprehensive list of food and drink products containing caffeine that they 
should avoid consuming in that period. 
 
Testing protocol 
Upper-body muscle strength and muscle endurance were assessed first, using the barbell 
bench press exercise. After the bench press exercise, lower-body muscle strength and muscle 
endurance were evaluated using the barbell back squat exercise. In the eccentric phase of the 
squat exercise, the participants were required to squat to a depth where the hips were at the 
same level as the knees for the attempt to be considered valid. None of the participants used 
knee wraps during the tests; five participants used a weight lifting belt, but its use was 
standardized across all conditions. Participants initially performed a self-selected warm-up 
lasting 10 minutes. For the 1RM, the first warm-up set included eight to ten repetitions with 
50% of the participants’ estimated 1RM. The second warm-up set included three to five 
repetitions with ~75% of the estimated 1RM. Participants then completed one repetition with 
~95% of their estimated 1RM. Based on whether the participant successfully lifted the load or 
not, the weight was increased or decreased on subsequent attempts. Three to five minutes 
were given between the 1RM attempts, and all 1RM values were obtained within five 
attempts. After a five-minute rest period, muscle endurance was assessed with one ‘all-out’ 




The test was terminated when the participants could not maintain the prescribed cadence (1-2 
seconds for both concentric and eccentric muscle actions) and/or could not maintain the whole 
range of motion of for the exercise. Following a five minute rest, the same procedure was 
repeated for lower-body muscle strength and muscle endurance.  
 
Rating of perceived exertion (RPE) and pain perception (PP) 
Within five seconds of a successful 1RM attempt, as well as following the final repetition in 
the muscle endurance tests (after re-racking the weight), the participants indicated their 
perceived levels of exertion on the RPE scale.13 Furthermore, the participants indicated their 
levels of PP on a previously validated scale.14 For the RPE scale, the responses ranged from 6 
to 20, while on the PP scale, the responses ranged from 0 to 10. Before the familiarization 
session, the participants were instructed on the proper use of the scales. Before the subsequent 
assessments, the participants were re-introduced with the scales.  
 
Assessment of blinding 
We tested the effectiveness of blinding by asking the participants to identify the supplement 
they had ingested. The question for this assessment was based on the study by Saunders et 
al.15 and was phrased: “Which supplement do you think you have ingested?” Its response 
scale included five possible answers: (a) caffeine 2 mg.kg−1; (b) caffeine 4 mg.kg−1; (c) 
caffeine 6 mg.kg−1; (d) placebo; (e) do not know. This assessment was conducted pre- and 






A series of repeated measures analysis of variance (ANOVA) was used to analyze the 
differences in performance and subjective responses between the conditions. In cases of a 
significant main effect, post hoc comparisons were conducted using Dunnett’s test so that 
each caffeine condition was compared to the placebo-control condition (i.e., 2 mg.kg−1 vs. 
placebo-control, 4 mg.kg−1 vs. placebo-control, and 6 mg.kg−1 vs. placebo-control) and to the 
no-placebo control condition (i.e., 2 mg.kg−1 vs. no-placebo control, 4 mg.kg−1 vs. no-placebo 
control, and 6 mg.kg−1 vs. no-placebo control). We have also calculated p-values for the linear 
and quadratic trends between the doses of caffeine. The statistical significance threshold was 
set at p<0.05. Relative effect sizes were calculated using Cohen’s d with 95% confidence 
intervals (95% CI) for repeated measures. Effect sizes of <0.20, 0.20 to 0.49, 0.50 to 0.79, and 
≥0.80 were considered to represent trivial, small, moderate, and large effects, respectively. In 
addition to relative effect sizes, we also calculated the raw mean differences between the trials 
and their 95% CIs. The blinding data were examined using the Bang’s Blinding Index with all 
three possible responses for caffeine (i.e., 2, 4, and 6 mg·kg-1) collapsed into a single caffeine 
response. The values in this index range from –1.0 which indicates opposite guessing to 1.0 
which indicates complete unblinding; here, we reported these data as a percentage of 
individuals who identified the correct condition beyond chance. All analyses were performed 
using the STATISTICA software (version 13.0; StatSoft, Tulsa, OK, USA). 
 
Results 
Lower-body muscle strength 
For 1RM strength in the back squat exercise a significant main effect of condition was 
observed (p=0.008; Table 1). In comparisons with the no-placebo control condition, post hoc 




(d=0.15; +3.5 kg; p=0.003). In comparisons with the no-placebo control condition, no 
significant differences were observed for 4 mg.kg−1 (d=0.09; +2.1 kg; p=0.069) and 6 mg.kg−1 
of caffeine (d=0.08; +2.0 kg; p=0.083). In comparisons with placebo-control condition, post 
hoc tests revealed that a dose of 2 mg.kg−1 of caffeine also acutely enhanced lower-body 
strength (d=0.13; +3.0 kg; p=0.009). In comparisons with placebo-control condition, no 
significant differences were observed for 4 mg.kg−1 (d=0.07; +1.6 kg; p=0.159) and 6 mg.kg−1 
of caffeine (d=0.06; +1.5 kg; p=0.185). The linear trend for the effectiveness of different 
doses of caffeine was not significant (p=0.162). The quadratic trend for the effectiveness of 
different doses of caffeine was not significant (p=0.541). 
 
Upper-body muscle strength 
For 1RM strength in the bench press exercise a significant main effect of condition was 
observed (p=0.025). In comparisons with the no-placebo control condition, post hoc test 
revealed that doses of 4 mg.kg−1 (d=0.07; +1.6 kg; p=0.044) and 6 mg.kg−1 (d=0.09; +2.1 kg; 
p=0.007) of caffeine acutely enhanced upper-body strength. In comparisons with no-placebo 
control condition, no significant differences were observed for 2 mg.kg−1 (d=0.01; +0.2 kg; 
p=0.656). In comparisons with placebo-control condition, post hoc tests revealed no 
significant differences for 2 mg.kg−1 (d=–0.03; –0.5 kg; p=0.923), 4 mg.kg−1 (d=0.04; +0.9 kg; 
p=0.287) and for 6 mg.kg−1 (d=0.06; +1.4 kg; p=0.100) doses of caffeine. We found a 
significant linear trend for the effectiveness of different doses of caffeine (p=0.020). The 
quadratic trend for the effectiveness of different doses of caffeine was not significant 
(p=0.508). 
 




For the number of repetitions in the back squat exercise a significant main effect of caffeine 
was observed (p=0.004). As compared to no-placebo control condition, post hoc tests 
revealed that doses of 2 mg.kg−1 (d=0.55; +4.2 repetitions; p=0.011), 4 mg.kg−1 (d=0.52; +3.3 
repetitions; p=0.046), and 6 mg.kg−1 (d=0.46; +3.9 repetitions; p=0.018) acutely enhanced 
lower-body muscle endurance. As compared to placebo-control condition, post hoc tests 
revealed that 2 mg.kg−1 of caffeine (d=0.67; +4.8 repetitions; p=0.008), 4 mg.kg−1 (d=0.68; 
+3.9 repetitions; p=0.032) and 6 mg.kg−1 (d=0.56; +4.5 repetitions; p=0.014) acutely 
enhanced lower-body muscle endurance. The linear trend for the effectiveness of different 
doses of caffeine was not significant (p=0.802). The quadratic trend for the effectiveness of 
different doses of caffeine was not significant (p=0.633). 
 
Upper-body muscle endurance 
The repeated measures ANOVA conducted for the number of repetitions in the bench press 
exercise did not show a significant main effect (p=0.470), and therefore no post hoc analysis 
was performed.  
 
RPE and PP  
None of the comparisons for the RPE or the PP were significant (p>0.05 for all). All data are 
presented in Table 2. 
 
Effectiveness of blinding  
Just before exercise, in the placebo-control, and the 2, 4, and 6 mg.kg−1 conditions, 1%, 11%, 




respectively. After exercise, in the placebo-control, and the 2, 4, and 6 mg.kg−1 conditions, 




This study found mixed effects of different doses of caffeine on muscle strength and 
endurance. Except for upper-body muscle strength, no clear dose-response trends were 
observed. The results suggested that only 2 mg.kg−1 of caffeine was ergogenic for lower-body 
strength, as compared to both control conditions. When considering the comparison with the 
no-placebo control condition, caffeine doses of 4 mg.kg−1 and 6 mg.kg−1 enhanced upper-body 
strength. Compared to both control conditions, all three caffeine doses were effective for 
acute improvements in lower-body muscle endurance, whereas no significant effects were 
found for any of the three caffeine doses on upper-body muscle endurance. 
 
Effects of caffeine on muscle strength 
Our results indicate that a caffeine dose of 2 mg.kg−1 acutely enhanced lower-body muscle 
strength. We did not find significant ergogenic effects for higher doses, even though the effect 
sizes favored the caffeine conditions. For upper-body strength, only 4 mg.kg−1 and 6 mg.kg−1 
doses of caffeine were ergogenic. However, it is important to consider that the results for the 
upper-body were statistically significant only when compared to no-placebo control, but not 





Our results support the findings of a previous meta-analysis that caffeine ingestion may 
acutely enhance 1RM strength.8 This meta-analysis found a pooled effect size of caffeine on 
strength of 0.20.8 Even though caffeine was ergogenic in our study, the effect size for strength 
ranged from 0.07 to 0.15 which can be considered as ‘trivial’. Mean changes in weight lifted 
which ranged from +1.6 to +3.5 kg, can be considered relatively small from a practical 
perspective. Such increases in strength would likely only be worthwhile in strength-based 
sports such as powerlifting, in which, narrow margins determine the competition outcomes. 
While we did not include competitive powerlifters in the study, several of the participants did 
indeed exhibit very high levels of strength. One participant had a 1RM in the squat of 185 kg, 
and another successfully performed the 1RM in the bench press exercise with 147.5 kg. Such 
levels of strength are similar to those previously observed in national level powerlifters.16 
This coupled with the fact that all of the participants were resistance-trained individuals 
increases the generalizability of these findings to athletes competing in strength-based sports; 
however, future work examining these effects among athletes from strength-based sports is 
warranted. For upper-body strength, we observed a significant linear trend between the dose 
of caffeine and strength performance. Indeed, average 1RM bench press values with caffeine 
doses of 2, 4, and 6 mg.kg−1 amounted to 106.3 kg, 107.8 kg, and 108.3 kg, respectively. 
Again, it needs to be highlighted that these differences in weight lifted are relatively small, 
which may call into question the practical relevance of these findings for most individuals.  
 
To date, only one study has explored the effects of multiple doses of caffeine on 1RM 
strength.9 In that study, the researchers did not find any significant effects of 2 and 5 mg.kg−1 
of caffeine on 1RM strength in the leg press exercise. There are several key differences in the 
study design between the present study and the work by Arazi et al.9 that may explain 




the Arazi et al.9 study was conducted in a sample of adolescent female karate athletes. This 
may be relevant given that the response to caffeine ingestion might not be uniform between 
men and women.5 Also, there were substantial differences in the total sample size (10 vs. 28 
participants), which may have affected statistical inferences. The average effect size for the 
effects of caffeine in the Arazi et al.9 study was 0.35, which might suggest that the effects 
would be statistically significant if the study included a larger sample size.  
 
Effects of caffeine on muscle endurance  
For lower-body muscle endurance, all three doses of caffeine were found to be ergogenic, in 
comparison to both control conditions. The average relative effect size spanned from 0.46 to 
0.67, which is considered as an indication of a ‘moderate’ effect. The mean differences in the 
number of performed repetitions in the back squat exercise ranged from 3 to 5. Such acute 
improvements in muscle endurance following caffeine ingestion are similar to those observed 
after eight weeks of regimented resistance exercise, which highlights the magnitude of these 
effects.17,18 For upper-body muscle endurance, no significant differences were observed 
between the caffeine conditions versus the control conditions.  
 
While caffeine is ergogenic for muscle endurance, these effects may be modulated by factors 
such as the size of the activated muscle.19 Previous research has suggested that the lower- and 
upper-body musculature exhibit divergent responses to caffeine ingestion with the effects 
being more pronounced in the lower-body musculature.20,21 In support of this idea, Warren et 
al.19 reported that caffeine has a greater ergogenic effect on the knee extensor muscles as 
compared to the smaller muscle groups such as the elbow flexors. During maximal voluntary 




muscle groups reach up to 99% of their maximum activation.22,23 Given these baseline 
differences in muscle activation levels between muscle groups, Warren et al.19 suggested that 
larger muscles, such as the knee extensors, are more responsive to the ergogenic effects of 
caffeine. In one study, at baseline, the percentage of motor-unit recruitment of the knee 
extensors and elbow flexors during maximal contractions—as assessed using the interpolated-
twitch electrical stimulation—was at 83% and 97%, respectively.20 Due to the lower muscle 
activation level at baseline, after the ingestion of caffeine, performance was only improved for 
the lower- but not the upper-body.20 These results might explain why we did not observe 
significant improvements in upper-body muscle endurance. Additionally, these results might 
explain why we did not find significant increases in upper-body strength following caffeine 
ingestion when compared to the placebo-control conditions. 
 
Thus far, only Polito and colleagues24 conducted a study that had a similar design to ours. In 
this study, 14 resistance-trained men performed three upper-body resistance exercises (chest 
press, shoulder press, and biceps curl exercises) for three sets until exhaustion with 70% of 
1RM after the ingestion of either 3 or 6 mg.kg−1 of caffeine. The results indicated that both 
doses of caffeine acutely increased the number of repetitions performed in the three upper-
body exercises. The reason for the discrepancies between the studies could be related to the 
protocol used. In the study by Polito et al.24 study, the participants performed a total of nine 
sets (three sets for each of the three exercises), whereas we used one ‘all-out’ set. Caffeine 
ingestion attenuates the fatigue-induced decline in muscle contractile properties,25 which may 
explain why caffeine was effective for upper-body muscles over a multiple set protocol, as in 
the study by Polito and colleagues, but not when using a single set. Given the overall lack of 




of caffeine’s effects on muscle endurance such as the exercise type (e.g. single vs. multiple 
sets).  
 
RPE and PP  
When analyzing the responses of the participants in the RPE and PP scales, no significant 
effects between the conditions were observed. These results suggest that mechanisms other 
than a reduction in RPE or PP are responsible for the ergogenic effects of caffeine. The 
ergogenic effects of caffeine in the present study might be explained by caffeine’s effects on 
increasing muscle fiber conduction velocity and motor unit recruitment.19,26 Nonetheless, it is 
also important to consider that the use of multiple tests of performance might have influenced 
the estimated effects of caffeine on RPE. For example, testing of strength in the bench press 
first in the testing session might have impacted the RPE responses in the upper-body muscle 
endurance test.  
 
Limitations of the study 
One of the limitations of the present study is that we did not measure blood caffeine 
concentrations, and therefore, the amount of caffeine absorption in the blood with different 
doses of caffeine remains unclear. Additionally, even though the majority of the participants 
were considered as ‘low’ habitual users (caffeine intake of <100 mg per day), several of the 
participants were moderate-to-high caffeine users with habitual intakes of >100 mg per day. 
Caffeine’s ergogenic effect might be more pronounced in individuals with low habitual 
caffeine consumption.27 Even though the findings from the studies on this matter are 
equivocal,27-29 this still needs to be acknowledged as a potential limitation of the current 




variation in the CYP1A2 gene. The CYP1A2 gene affects caffeine metabolism; individuals 
with the AA genotype seems to experience greater improvements in exercise performance 
than those with the AC/CC genotype.30 In this study, we did not collect data on genotype 
variations which is something that future studies may consider. Finally, the blinding of the 
participants was generally effective, even though the percentage of those that correctly 
guessed the treatment identity beyond chance increased pre to post-exercise. In this context, it 
is possible that the pre-exercise responses are of greater importance, given that the post-
exercise responses might be influenced by the improved performance (or lack thereof) during 
the testing session.  
 
Practical implications 
As little as 2 mg.kg−1 of caffeine may enhance lower-body muscle endurance. While caffeine 
ingestion was ergogenic for lower and upper-body strength, the magnitude of these effects can 
be categorized as trivial.  
 
Conclusions  
In this study, we found a linear trend between the dose of caffeine and its effects on upper-
body strength. However, this study found no clear association between the dose of caffeine 
and the magnitude of its ergogenic effects for lower-body strength and muscle endurance. 
While our findings indicate that caffeine ingestion may enhance upper- and lower-body 
strength, from a practical standpoint, the magnitude of this effect is of questionable relevance. 
A low dose of caffeine (i.e., 2 mg.kg−1)—for an 80 kg individual this dose of caffeine is 




body resistance exercise performance with the magnitude of the effect being similar to that 
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Figure 1. An overview of the experimental protocol. 1RM: one repetition maximum, RPE: completing the rating of perceived exertion scale; 







Table 1. Summary of the study comparision between the conditions 
Outcome Comparision Cohen’s d (95% CI) Raw mean difference (95% CI) r 
Weight lifted in the 1RM barbell back 
squat test 
No-placebo control vs. 2 mg.kg−1 0.15 (0.08, 0.22)* +3.5 kg (1.9, 5.1 kg)* 0.99 
No-placebo control vs. 4 mg.kg−1 0.09 (–0.01, 0.19) +2.1 kg (–0.2, 4.4 kg) 0.97 
No-placebo control vs. 6 mg.kg−1 0.08 (0.00, 0.17) +2.0 kg (0.0, 4.0 kg) 0.98 
Placebo-control vs. 2 mg.kg−1 0.13 (0.06, 0.20)* +3.0 kg (1.4, 4.6 kg)* 0.98 
Placebo-control vs. 4 mg.kg−1 0.07 (–0.03, 0.17) +1.6 kg (–0.6, 3.8 kg) 0.97 
Placebo-control vs. 6 mg.kg−1 0.06 (–0.03, 0.16) +1.5 kg (–0.5, 3.5 kg) 0.98 
Weight lifted in the 1RM barbell bench 
press test 
No-placebo control vs. 2 mg.kg−1 0.01 (–0.05, 0.06) +0.2 kg (–1.0, 1.4 kg) 0.99 
No-placebo control vs. 4 mg.kg−1 0.07 (0.00, 0.15)* +1.6 kg (0.0, 3.3 kg)* 0.98 
No-placebo control vs. 6 mg.kg−1 0.09 (0.03, 0.16)* +2.1 kg (0.9, 3.4 kg)* 0.99 
Placebo-control vs. 2 mg.kg−1 –0.03 (–0.10, 0.05) –0.5 kg (–2.0, 0.9 kg) 0.98 
Placebo-control vs. 4 mg.kg−1 0.04 (–0.05, 0.14) +0.9 kg (–1.1, 2.9 kg) 0.97 
Placebo-control vs. 6 mg.kg−1 0.06 (0.00, 0.14) +1.4 kg (0.0, 2.9 kg) 0.99 
Number of repetition in the lower-body 
muscle endurnace test 
No-placebo control vs. 2 mg.kg−1 0.55 (0.21, 0.92)* +4.2 repetitions (1.9, 6.5 repetitions)* 0.76 
No-placebo control vs. 4 mg.kg−1 0.52 (0.07, 0.97)* +3.3 repetitions (0.6, 5.9 repetitions)* 0.46 
No-placebo control vs. 6 mg.kg−1 0.46 (0.01, 0.92)* +3.9 repetitions (0.4, 7.3 repetitions)* 0.51 
Placebo-control vs. 2 mg.kg−1 0.67 (0.17, 1.21)* +4.8 repetitions (1.4, 8.1 repetitions)* 0.36 
Placebo-control vs. 4 mg.kg−1 0.68 (0.22, 1.17)* +3.9 repetitions (1.5, 6.3 repetitions)* 0.48 
Placebo-control vs. 6 mg.kg−1 0.56 (0.01, 1.16)* +4.5 repetitions (0.1, 8.8 repetitions)* 0.08 







Table 2. Summary of the exercise performance data and the responses to the rating of perceived exertion and pain perception scales under the 
five employed conditions  
Variable Control condition Caffeine intake condition (dose) 
No-placebo Placebo 2 mg.kg−1 4 mg.kg−1 6 mg.kg−1 
1RM barbell back squat (kg) 128.7 ± 23.8 129.2 ± 21.7 132.2 ± 22.7a, b 130.8 ± 22.8 130.7 ± 24.6 
RPE for 1RM barbell back squat (6-20 scale) 16.4 ± 2.6 17.0 ± 2.0 17.0 ± 1.8 16.9 ± 1.8 16.4 ± 2.2 
PP for 1RM barbell back squat (0-10 scale) 2.3 ± 2.2 2.3 ± 2.8 2.8 ± 2.8 2.2 ± 2.5 2.1 ± 2.5 
1RM barbell bench press (kg) 106.2 ± 21.6 106.9 ± 21.9 106.3 ± 21.1 107.8 ± 20.7a 108.3 ± 22.5a 
RPE for 1RM barbell bench press (6-20 scale) 16.3 ± 2.3 15.9 ± 2.8 15.3 ± 2.8 15.7 ± 2.6 15.9 ± 2.7 
PP for 1RM barbell bench press (0-10 scale) 1.8 ± 2.4 1.4 ± 2.2 1.9 ± 2.5 1.8 ± 2.2 1.6 ± 1.9 
Barbell back squat – repetitions to failure with 60% of 1RM 
(repetitions) 
21.7 ± 6.2 21.1 ± 4.9 25.9 ± 8.4a, b 25.0 ± 6.1a, b 25.5 ± 9.5a, b 
RPE for barbell back squat repetitions to failure (6-20 scale) 16.7 ± 2.6 16.9 ± 2.4 17.0 ± 2.3 17.1 ± 2.6 17.2 ± 2.4 
PP for barbell back squat repetitions to failure (0-10 scale) 2.9 ± 2.7 3.2 ± 2.7 3.5 ± 3.1 3.5 ± 3.1 3.0 ± 3.0 
Barbell bench press – repetitions to failure with 60% of 1RM 
(repetitions) 
20.5 ± 3.9 20.5 ± 4.2 21.1 ± 3.8 21.2 ± 3.6 20.9 ± 4.0 
RPE for barbell bench press repetitions to failure (6-20 scale) 16.8 ± 2.3 17.0 ± 2.4 16.6 ± 2.4 16.9 ± 2.4 17.0 ± 2.5 
PP for barbell bench press repetitions to failure (0-10 scale) 2.4 ± 2.6 2.3 ± 2.7 2.5 ± 3.2 2.3 ± 2.2 2.3 ± 2.7 
All data are presented as mean ± standard deviation, RPE: rating of perceived exertion, PP: pain perception, 1RM: one repetition maximum; a: 
significant difference as compared to no-placebo control b: significant difference as compared to placebo-control 
 
 
